FDA Inspection 1119189 — Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
The FDA completed an inspection of Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy on February 20, 2020 in Murrieta, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 20, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Murrieta, CA (United States)